BREAST CYTOPATHOLOGY

166 Index
Apocrine carcinoma
in axillary apocrine glands,
124
clinical features of, 121–122
cytomorphologic
characteristics of, 115,
122–123
differential diagnoses of,
124
invasive micropapillary
carcinoma, 106
lipid-rich carcinoma, 107
as “gray zone diagnosis”
cause, 28
Apocrine metaplastic cells,
differentiated from
granular cell tumors, 75
Atypia, cytologic, 1–2
intraductal papilloma-related,
71, 72
misdiagnosis of, 5
B
Benign and borderline breast
tumors, 57–84
Benign mixed tumors, 75, 127
Biopsy, indications for, 3
BRCA1/BRCA2 gene
mutations, as breast
cancer risk factor, 91
Breast cancer/carcinoma. See
also specific types of
breast cancer/carcinoma
fine-needle aspiration
cytologic criteria for, 12
incidence of, 1
“triple diagnostic approach”
to, 1–2, 3, 4
Breast lesions
biphasic, differentiated from
adenomyoepithelioma,
82
nonpalpable, fine-needle
aspiration/core biopsy
of, 14
palpable
fibrocystic changes-related,
19
fine-needle aspiration/core
biopsy of, 13
Breast tissue, with normal
histology, 5, 6
differentiated from
hamartoma, 83
C
CAPSS (“columnar alterations
with prominent apical
snouts and secretions”),
28–29
Carcinoid tumors, metastatic,
130
Carcinoma in situ
columnar cell lesions
associated with, 28
ductal, breast ductal lavage
of, 161–162
in fibroadenomas, 57
lobular, breast ductal lavage
of, 161–162
Carcinoma with osteoclastictype
giant cells, 127–128
Carcinosarcoma, 125
Cell blocks, 4
Cervical cancer, metastatic,
143, 144
Children, intraductal papilloma
in, 68
Chondroid syringoma, 75–77
Clear-cell carcinoma,
glycogen-rich, 121
Colloid (mucinous) carcinoma,
107–110
clinical features of, 107–108